VivoSim Labs, Inc. Basic Shares Outstanding (Weighted Average)
VivoSim Labs, Inc. (VIVS) reported Basic Shares Outstanding (Weighted Average) of 5.24 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 5.24M shares, a 109.27% increase year-over-year.
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 2.64M shares, a 62.12% increase year-over-year.
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 2.61M shares, a 73.32% increase year-over-year.
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 2.60M shares, a 73.72% increase year-over-year.
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic for fiscal 2026 was 2.59M shares, a 76.85% increase from fiscal 2025.
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 1.46M shares, a 92.06% increase from fiscal 2024.
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 762.08K shares, a 91.25% decline from fiscal 2023.
- VivoSim Labs, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 8.71M shares, a 0.11% increase from fiscal 2022.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.24M shares 10-Q · filed 2026-08-12 | 3.94M shares derived: average of 2 quarters · filed 2026-08-12 | 3.49M shares derived: average of 3 quarters · filed 2026-08-12 | 3.27M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | 2.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | 2.62M shares derived: average of 2 quarters · filed 2026-07-14 | 2.62M shares derived: average of 3 quarters · filed 2026-07-14 | 2.59M shares 10-K · filed 2026-07-14 | ||||
| 2025-12-31 | 2.61M shares 10-Q · filed 2026-02-11 | 2.61M shares derived: average of 2 quarters · filed 2026-02-11 | 2.57M shares 10-Q · filed 2026-02-11 | 2.34M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-09-30 | 2.60M shares 10-Q · filed 2025-11-06 | 2.55M shares 10-Q · filed 2025-11-06 | 2.24M shares derived: average of 3 quarters · filed 2026-08-12 | 2.06M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | 2.50M shares 10-Q · filed 2026-08-12 | 2.06M shares derived: average of 2 quarters · filed 2026-08-12 | 1.88M shares derived: average of 3 quarters · filed 2026-08-12 | 1.78M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | 1.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | 1.57M shares derived: average of 2 quarters · filed 2026-07-14 | 1.54M shares derived: average of 3 quarters · filed 2026-07-14 | 1.46M shares 10-K · filed 2026-07-14 | ||||
| 2024-12-31 | 1.50M shares 10-Q · filed 2026-02-11 | 18.06M shares 10-Q · filed 2025-02-19 | 1.50M shares derived: average of 2 quarters · filed 2026-02-11 | 1.41M shares 10-Q · filed 2026-02-11 | 16.91M shares 10-Q · filed 2025-02-19 | -4.82M shares derived: average of 4 quarters · filed 2026-02-11 | ||
| 2024-09-30 | 1.50M shares 10-Q · filed 2025-11-06 | 17.99M shares 10-Q · filed 2024-11-08 | 1.36M shares 10-Q · filed 2025-11-06 | 16.34M shares 10-Q · filed 2024-11-08 | -6.93M shares derived: average of 3 quarters · filed 2025-11-06 | -2.92M shares derived: average of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | 1.22M shares 10-Q · filed 2025-08-12 | 14.66M shares 10-Q · filed 2024-08-05 | -11.14M shares derived: average of 2 quarters · filed 2025-08-12 | -4.39M shares derived: average of 3 quarters · filed 2025-08-12 | -1.11M shares derived: average of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | -23.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-05 | -7.19M shares derived: average of 2 quarters · filed 2025-06-05 | -1.89M shares derived: average of 3 quarters · filed 2025-06-05 | 762.08K shares 10-K · filed 2025-06-05 | 9.14M shares 10-K · filed 2024-05-31 | |||
| 2023-12-31 | 9.12M shares 10-Q · filed 2025-02-19 | 8.92M shares derived: average of 2 quarters · filed 2025-02-19 | 8.85M shares 10-Q · filed 2025-02-19 | 8.82M shares derived: average of 4 quarters · filed 2025-02-19 | ||||
| 2023-09-30 | 8.72M shares 10-Q · filed 2024-11-08 | 8.72M shares 10-Q · filed 2024-11-08 | 8.72M shares derived: average of 3 quarters · filed 2024-11-08 | 8.72M shares derived: average of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | 8.72M shares 10-Q · filed 2024-08-05 | 8.72M shares derived: average of 2 quarters · filed 2024-08-05 | 8.72M shares derived: average of 3 quarters · filed 2024-08-05 | 8.71M shares derived: average of 4 quarters · filed 2024-08-05 | ||||
| 2023-03-31 | 8.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-31 | 8.71M shares derived: average of 2 quarters · filed 2024-05-31 | 8.71M shares derived: average of 3 quarters · filed 2024-05-31 | 8.71M shares 10-K · filed 2024-05-31 | ||||
| 2022-12-31 | 8.71M shares 10-Q · filed 2024-02-08 | 8.71M shares derived: average of 2 quarters · filed 2024-02-08 | 8.71M shares 10-Q · filed 2024-02-08 | 8.71M shares derived: average of 4 quarters · filed 2024-02-08 | ||||
| 2022-09-30 | 8.71M shares 10-Q · filed 2023-11-09 | 8.71M shares 10-Q · filed 2023-11-09 | 8.71M shares derived: average of 3 quarters · filed 2023-11-09 | 8.71M shares derived: average of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | 8.71M shares 10-Q · filed 2023-08-10 | 8.71M shares derived: average of 2 quarters · filed 2023-08-10 | 8.71M shares derived: average of 3 quarters · filed 2023-08-10 | 8.71M shares derived: average of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | 8.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | 8.71M shares derived: average of 2 quarters · filed 2023-07-14 | 8.71M shares derived: average of 3 quarters · filed 2023-07-14 | 8.70M shares 10-K · filed 2023-07-14 | ||||
| 2021-12-31 | 8.71M shares 10-Q · filed 2023-02-09 | 8.71M shares derived: average of 2 quarters · filed 2023-02-09 | 8.70M shares 10-Q · filed 2023-02-09 | |||||
| 2021-09-30 | 8.71M shares 10-Q · filed 2022-11-10 | 8.70M shares 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | 8.70M shares 10-Q · filed 2022-08-11 | |||||||
| 2013-09-30 | 72.72M shares 10-Q · filed 2013-11-08 | 68.78M shares 10-Q · filed 2013-11-08 | ||||||
| 2012-09-30 | 44.10M shares 10-Q · filed 2013-11-08 | 43.61M shares 10-Q · filed 2013-11-08 | 39.35M shares 10-Q · filed 2012-11-14 | |||||
| 2011-09-30 | 12.26M shares 10-Q · filed 2012-11-14 | 11.54M shares 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |